Operating conditions for the medical technology capital goods industry have improved in recent months, although residual problems born out of COVID-19 are lingering.
But as the pandemic has tapered out, the challenges for health care systems, providers and clinicians have evolved differently to those of manufacturers
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?